Advertisement

Legal & Regulatory Issues

New Brunswick, N.J.-based Johnson & Johnson has agreed to pay up to $2.2 billion to settle U.S. investigations and lawsuits regarding its marketing practices for Risperdal, an antipsychotic drug, and other pharmaceuticals, according to a Bloomberg report.

An appeals court overturned a $1.13 million decision against Blue Cross Blue Shield of Michigan yesterday, finding that the payor validly contracted with Calhoun County and did not hide fees in its contracts, according to a Crain's Detroit Business report.

Advertisement

Speaking at White House town hall meeting on women's health Thursday, HHS Secretary Kathleen Sebelius said an overturning of the entire Patient Protection and Affordable Care Act would have a "pretty cataclysmic impact" on the nation, according to a Nurse.com…

The U.S. House of Representatives voted by a 270 to 146 margin to strike down a 2.3 percent tax on medical devices, according to a Reuters report.

Atlanta-based Emory Healthcare is facing a class-action lawsuit over a data breach that occurred in April, when the system lost 10 discs containing personal information for roughly 315,000 patients, according to an Atlanta Journal-Constitution report.

Advertisement